Page 120 - Read Online
P. 120

Table 1: Major leukocyte inflammatory mediators and    smoking and alcohol consumption as risk factors for aneurysmal
           targeted therapies for intracranial aneurysms          subarachnoid hemorrhage. Stroke 1993;24:639‑46.
                                                              8.   Krex  D, Schackert  HK, Schackert  G. Genesis of cerebral
           Major                   Targeted therapies for         aneurysms – an update. Acta Neurochir (Wien) 2001;143:429‑48.
           molecules               intracranial aneurysms
                                                              9.   Aoki T, Kataoka H, Ishibashi R, Nozaki K, Egashira K, Hashimoto N.
           Common inflammatory                                    Impact of monocyte chemoattractant protein‑1 deficiency on
           mediators                                              cerebral aneurysm formation. Stroke 2009;40:942‑51.
            TNF-α                  DTH [18]                   10.  Aoki  T, Kataoka  H, Morimoto  M, Nozaki  K, Hashimoto  N.
            NF-κB                  Decoy ODN [45]                 Macrophage‑derived matrix metalloproteinase‑2 and ‑9 promote
            Ets-1                  Decoy ODN [45]                 the progression of cerebral aneurysms in rats. Stroke 2007;38:162‑9.
            VCAM-1                                            11.  Bruno G, Todor R, Lewis I, Chyatte D. Vascular extracellular matrix
            iNOS
            L-selectin                                            remodeling in cerebral aneurysms. J Neurosurg 1998;89:431‑40.
            MCP-1                  7ND [9]                    12.  Frösen J, Piippo  A, Paetau  A, Kangasniemi  M, Niemelä M,
            SDF-1                  Blocking anti-SDF-1 antibody [47]  Hernesniemi J, Jaaskelainen J. Remodeling of saccular cerebral
           Macrophages                                            artery aneurysm wall is associated with rupture: histological analysis
            IL-1β, IL-2, IL-6, IL-23                              of 24 unruptured and 42 ruptured cases. Stroke 2004;35:2287‑93.
            MIP-1α                                            13.  Kanematsu Y, Kanematsu M, Kurihara C, Tada Y, Tsou TL, van
            Cathepsins             NC-23000 [56]                  Rooijen N, Lawton MT, Young WL, Liang EI, Nuki Y, Hashimoto T.
            MMP-2, MMP-9           Tolylsam (selective) and       Critical  roles  of  macrophages  in  the  formation  of  intracranial
                                   doxycline (broad) [10,49,52]   aneurysm. Stroke 2011;42:173‑8.
           Neutrophils                                        14.  Kilic T, Sohrabifar M, Kurtkaya O, Yildirim O, Elmaci I, Günel M,
            IL-1β                                                 Pamir M. Expression of structural proteins and angiogenic factors
            Neutrophil elastase                                   in normal arterial and unruptured and ruptured aneurysm walls.
           Lymphocytes                                            Neurosurgery 2005;57:997‑1007.
            IFN-γ                                             15.  Shi C, Awad IA, Jafari N, Lin S, Du P, Hage ZA, Shenkar R, Getch C,
            IL-6
           Mast cells                                             Bredel M, Batjer H, Bendok B. Genomics of human intracranial
            IL-1, IL-3, IL-4, IL-5,   Degranulation inhibitors (tranilast   aneurysm wall. Stroke 2009;40:1252‑61.
            IL-8, IL-13            and emedastine difumarate) [65]  16.  Aoki T, Nishimura M, Matsuoka T, Yamamoto K, Furuyashiki T,
            TGF-β                                                 Kataoka H, Kitaoka S, Ishibashi R, Ishibazawa A, Miyamoto S,
           TNF‑α: tumor necrosis factor‑alpha; DTH: 3,6’dithiothalidomide; NF‑κB: nuclear   Morishita  R, Ando  J, Hashimoto  N, Nozaki  K, Narumiya  S.
           factor‑κB; ODN: oligodeoxynucleotide; VCAM‑1: vascular cell adhesion molecule;   PGE(2)  ‑EP(2) signalling in endothelium is activated by
           iNOS: inducible nitric oxide synthase; MCP‑1: monocyte chemoattractant   haemodynamic stress and induces cerebral aneurysm through an
           protein‑1; 7ND: N‑terminal deletion variant of MCP‑1; SDF‑1: stromal   amplifying loop via NF‑kappaB. Br J Pharmacol 2011;163:1237‑49.
           cell‑derived factor 1; MMP: matrix metalloproteinase; MIP‑1α: macrophage   17.  Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF,
           inflammatory proteins‑1‑alpha; IFN‑γ: interferon gamma; TGF‑β: transforming   Rosenwasser RH, Owens GK, Koch WJ, Greig NH, Dumont AS.
           growth factor beta; IL: interleukin
                                                                  TNF‑α induces phenotypic modulation in cerebral vascular smooth
                                                                  muscle cells: implications for cerebral aneurysm pathology. J Cereb
                                                                  Blood Flow Metab 2013;33:1564‑73.
           REFERENCES                                         18.  Starke RM, Chalouhi N, Jabbour PM, Tjoumakaris SI, Gonzalez LF,
                                                                  Rosenwasser RH, Wada K, Shimada K, Hasan D, Greig N, Owens G,
           1.   Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ,   Dumont A. Critical role of TNF‑α in cerebral aneurysm formation
              Dai  S, Ford  ES, Fox  CS, Franco  S, Fullerton  HJ, Gillespie  C,   and progression to rupture. J Neuroinflammation 2014;11:77.
              Hailpern  SM, Heit  JA, Howard  VJ, Huffman  MD, Judd  SE,   19.  Jayaraman T, Berenstein V, Li X, Mayer J, Silane M, Shin YS,
              Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD,   Niimi  Y, Klç T, Gunel  M, Berenstein  A. Tumor necrosis factor
              Mackey  RH, Magid  DJ, Marcus  GM, Marelli  A, Matchar  DB,   alpha is a key modulator of inflammation in cerebral aneurysms.
              McGuire DK, Mohler ER, Moy CS, Mussolino ME, Neumar RW,   Neurosurgery 2005;57:558‑64.
              Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J,   20.  Chyatte  D, Bruno  G, Desai  S, Todor  DR. Inflammation and
              Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB.   intracranial aneurysms. Neurosurgery 1999;45:1137‑46.
              Executive summary: heart disease and stroke statistics – 2014   21.  Hashimoto T, Meng H, Young WL. Intracranial aneurysms: links
              update: a report from the American Heart Association. Circulation   among inflammation, hemodynamics and vascular remodeling.
              2014;129:399‑410.                                   Neurol Res 2006;28:372‑80.
           2.   Feigin  VL, Lawes  CM, Bennett  DA, Anderson  CS. Stroke   22.  Turjman AS, Turjman F, Edelman ER. Role of fluid dynamics and
              epidemiology: a review of population‑based studies of incidence,   inflammation in intracranial aneurysm formation.  Circulation
              prevalence, and case‑fatality in the late 20th century. Lancet Neurol   2014;129:373‑82.
              2003;2:43‑53.                                   23.  Penn  DL, Komotar  RJ, Sander Connolly  E. Hemodynamic
           3.   Wardlaw  JM, White  PM. The detection and management of   mechanisms underlying cerebral aneurysm pathogenesis.  J Clin
              unruptured intracranial aneurysms. Brain 2000;123:205‑21.  Neurosci 2011;18:1435‑8.
           4.   Hop JW, Rinkel GJ, Algra A, van Gijn J. Case‑fatality rates and   24.  Chien S. Effects of disturbed flow on endothelial cells. Ann Biomed
              functional outcome after subarachnoid hemorrhage: a systematic   Eng 2008;36:554‑62.
              review. Stroke 1997;28:660‑4.                   25.  Nagel T, Resnick N,  Dewey  CF  Jr, Gimbrone MA  Jr.  Vascular
           5.   Chalouhi N, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez LF,   endothelial cells respond to spatial gradients in fluid shear stress by
              Rosenwasser RH, Rosenwasser R, Koch W, Dumont A. Biology of   enhanced activation of transcription factors. Arterioscler Thromb
              intracranial aneurysms: role of inflammation. J Cereb Blood Flow   Vasc Biol 1999;19:1825‑34.
              Metab 2012;32:1659‑76.                          26.  Tardy Y, Resnick N, Nagel T, Gimbrone MA Jr, Dewey CF Jr. Shear
           6.   Chalouhi N, Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI,   stress gradients remodel endothelial monolayers in vitro via a cell
              Gonzalez LF, Rosenwasser RH, Koch WJ, Dumont AS. Cigarette   proliferation‑migration‑loss cycle.  Arterioscler Thromb Vasc Biol
              smoke and inflammation: role in cerebral aneurysm formation and   1997;17:3102‑6.
              rupture. Mediators Inflamm 2012;2012:271582.    27.  Burridge K, Chrzanowska‑Wodnicka M. Focal adhesions, contractility,
           7.   Juvela  S, Hillbom  M, Numminen  H, Koskinen  P. Cigarette   and signaling. Annu Rev Cell Dev Biol 1996;12:463‑518.


            112                                              Neuroimmunol Neuroinflammation | Volume 2 | Issue 2 | April 15, 2015
   115   116   117   118   119   120   121   122   123   124   125